$BHVN.US ranked positive on November 1st, 2022

Biohaven Ltd – (BHVN, +1, November 1st)  We ranked this stock +N on October 7th based on purchases of $5 million from Vladimir Coric (CEO since 2022) at $10.31, and $2.5 million from John Childs (Director since 2022) at $8.98. This entity was spun-out of Pfizer in July 2022 after Pfizer purchased Biohaven Pharmaceutical Holdings […]

Read More